TXMD - TherapeuticsMD, Inc. Revenue Dynamics YoY (Last Twelve Months)

Brandmark of TherapeuticsMD (TXMD)

TherapeuticsMD, Inc. (TXMD) relied on the demand for bioidentical hormones, as evidenced by the percentage change in sales over the last 12 months compared to the previous 12 months. While the company previously implemented innovative formulas to enhance therapy safety, this metric is currently fixed at 34.00. This coincided with a reduction in R&D activity and a business transition toward simple commercial support for legacy products.

TherapeuticsMD, Inc. (TXMD) Sales Growth YoY (Last Twelve Months): for the period 02/11/2024 - 11/18/2026

Summary analytical data breakdowns for TherapeuticsMD Inc (TXMD)

- current price and projected stock value:
Summary company analytics:TherapeuticsMD, Inc.
Original product of TherapeuticsMD

TherapeuticsMD, Inc. (TXMD) is currently transforming its business model, shifting from direct sales to the licensing of intellectual property. This indicator captures revenue dynamics, neutralizing the time gap between quarterly reports. By analyzing the 12-month revenue growth rate year-over-year, an investor can observe the continuous speed of the company's adaptation to new market conditions. The TTM rolling calculation allows for the prompt detection of stagnation or growth in cash flows, which is critical for assessing the effectiveness of the current management restructuring.